Position in NTLA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$34,479,209
+$26,751,839 QoQ
Shares Held
2,689,486
+212.9% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Mar 31, 2026CallValue
$7,291,657
CallShares
568,772
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NTLA ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in NTLA
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,291,657 | 568,772 | Call | Defined | 2026-05-05 | |
| 2026-03-31 | $34,479,209 | 2,689,486 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,399,874 | 378,184 | Call | Defined | 2026-01-29 | |
| 2025-12-31 | $7,727,370 | 859,552 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $19,138,370 | 1,108,186 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $8,563,778 | 495,876 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $8,262,588 | 880,873 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $2,257,850 | 240,709 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $8,011,574 | 1,126,804 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $20,309,012 | 1,741,768 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,721,776 | 278,432 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $383,216 | 18,648 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $5,719,229 | 255,551 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,121,930 | 331,586 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,370,235 | 274,524 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,921,101 | 124,007 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,499,957 | 134,869 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,330,967 | 89,374 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,336,406 | 181,611 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,740,248 | 48,968 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,428,267 | 46,914 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,470,780 | 34,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $7,207,337 | 99,179 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,615,099 | 115,148 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,646,503 | 64,454 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,000,782 | 49,415 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,182,168 | 52,111 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,851,624 | 125,949 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,501,655 | 75,536 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,802,254 | 85,740 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $998,811 | 81,669 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||